Levofloxacin/Dexamethasone

左氧氟沙星/地塞米松

Report date: 2026/03/06 20:02:51

Base Information

Drug NameLevofloxacin/Dexamethasone
Drug Alias NameDucressaNTC-010
ClassificationSmall molecules > SteroidsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionGlucocorticoid receptor agonistsBacterial DNA gyrase inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIGlucocorticoid receptorBacterial DNA gyrase
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsOcular inflammation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIreland
Original Approved DateN/A
Country/TerritoryIrelandUnited KingdomEU +[4] 
CombinationsYes LevofloxacinDexamethasone
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesNtc SrlSanten
China Registration ClassN/A

Develop Information

Active CompaniesSanten OyNtc Srl
Inactive CompaniesTubilux Pharma SpaZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Active IndicationsOcular inflammation
Inactive IndicationsN/A

Other Information

ATC CodeS01CA01
Related LinksN/A